To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1078052
Sale price1.168,44 €
|
Brivaracetam Related Compound B (15 mg) ((R)-2-[(S)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) |
F21370 | 357336-99-3 | 1.168,44 € | |
|
USP-1078074
Sale price1.022,39 €
|
Brivaracetam Related Compound D (25 mg) ((S)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanoic acid) |
F213A0 | 943986-67-2 | 1.022,39 € | |
|
USP-1078245
Sale price979,16 €
|
Budesonide Related Compound E (25 mg) (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione) |
R07730 | 131918-64-4 | 979,16 € | |
|
USP-1078267
Sale price999,02 €
|
Budesonide Related Compound G (25 mg) (16alpha,17-[butylidenebis(oxy)]-11beta, 21-dihydroxypregna-4-ene-3,20-dione) |
R07770 | 137174-25-5 | 999,02 € | |
|
USP-1078289
Sale price1.028,23 €
|
Budesonide Related Compound L (25 mg) (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) |
R07760 | 216453-74-6 | 1.028,23 € | |
|
USP-1078325
Sale price1.023,56 €
|
Bumetanide Related Compound A (10 mg) (3-Amino-4-phenoxy-5-sulfamoylbenzoic acid) |
R122X1 | 28328-54-3 | 1.023,56 € | |
|
USP-1078336
Sale price1.076,14 €
|
Bumetanide Related Compound B (25 mg) (3-Nitro-4-phenoxy-5-sulfamoylbenzoic acid) |
R240N0 | 28328-53-2 | 1.076,14 € | |
|
USP-1078518
Sale price1.008,37 €
|
Bupivacaine Related Compound A (50 mg) (6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide |
F1F154 | N/A | 1.008,37 € | |
|
USP-1078529
Sale price949,94 €
|
Bupivacaine Related Compound B (50 mg) N-(2,6-Dimethylphenyl)piperidine-2-carboxamide hydrochloride |
R18960 | 65797-42-4 | 949,94 € | |
|
USP-1078573
Sale price1.097,17 €
|
Buspirone Related Compound A (2 x 75 mg) (2-(Piperazin-1-yl)pyrimidine) |
R131X0 | 20980-22-7 | 1.097,17 € | |
|
USP-1078642
Sale price1.055,10 €
|
Buspirone Related Compound K (50 mg) (8-azaspiro[4.5]decane-7,9-dione) |
R129G0 | 1075-89-4 | 1.055,10 € | |
|
USP-1078697
Sale price1.030,57 €
|
Buprenorphine Related Compound B CII (25 mg) ((S)-2-(4,5alpha-Epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl)-3,3-dimethylbutan-2-ol hydrochloride) |
F17880 | 209963-02-0 | 1.030,57 € | |
|
USP-1078711
Sale price1.028,23 €
|
Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]-3,3-dimethylbutan-2-ol) |
R137X0 | 457071-73-7 | 1.028,23 € | |
|
USP-1078722
Sale price1.173,12 €
|
Buprenorphine System Suitability Mixture CII (50 mg) (Mixture of Buprenorphine and about 0.5% of Ethenobuprenorphine) |
F05320 | N/A | 1.173,12 € | |
|
USP-1078744
Sale price1.088,99 €
|
Bupropion Hydrochloride Related Compound A (15 mg) (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride) |
R127R0 | 1049718-72-0 | 1.088,99 € | |
|
USP-1078755
Sale price1.067,96 €
|
Bupropion Hydrochloride Related Compound B (10 mg) (2-(tert-butylamino)-3'-bromopropiophenone hydrochloride) |
R156V0 | 1049718-43-5 | 1.067,96 € | |
|
USP-1078766
Sale price1.228,03 €
|
Bupropion Hydrochloride Related Compound C (40 mg) (1-(3-chlorophenyl)-2-hydroxypropan-1-one |
R060N0 | N/A | 1.228,03 € | |
|
USP-1078799
Sale price1.150,92 €
|
Bupropion Hydrochloride Related Compound F (40 mg) (1-(3-chlorophenyl)-1-hydroxypropan-2-one |
R109B0 | 857233-13-7 | 1.150,92 € | |
